Logo

LUCASBIO
HOME Contact Us
  • ABOUT
  • Key Personnel
    • ABOUT

    Key Personnel

    • Keon-il Im / Research Director

      • 18 SCI Research Articles
      • 30 Patent Applications
      • 4 Technology Transfer Cases
      • 2 Government Projects as Principal Investigator
      • 2 Industry-related Projects as Principal Investigator

      Professional Experience

      • Research Director
        Director of Research, LUCASBIO
      • Research Professor
        Conversant Research Consorcium in Immunologic Disease (CRCID), Seoul St. Mary's Hospital, The Catholic University of Korea
      • Chief Research Scientist
        Institute for Translational Research and Molecular Imaging College of Medicine, The Catholic University of Korea
      • Research Fellow
        College of Medicine, The Catholic University of Korea

      Education

      • Ph.D. in Immunology & Microbiology, Department of Biomedicine & Health Science, The Catholic University of Korea
      Research Projects as Princpal Investigator
      2020-2022 Study of TLR agonist to promote immune reconstitution following autologous hematopoietic stem cell transplantation and to improve elimination of minimal residual disease in relapse/refractory lymphoma patients
      2020-2021 Evidence establishing study for the commercialization of placenta derived mesenchymal stroma cell therapy in graft-versus-host disease
      2020-2021 Development of SARS-CoV-2 antigen specific dual targeting killer cell therapy for the treatment of COVID-19
      2016-2019 Pathophysiological regulation of graft-versus-host disease through the inhibition of HMGB1 signaling pathway
      Honors and Awards
      2019 Gold Award, 2019 Seoul St. Mary’s Hospital R&D Fair
      2019 Letter of Appreciation, The 6th Annual Meeting of the Korean Society of Experimental Hematology, A novel TLR5 agonist protects intestinal Lgr5+ stem cells through activates host-derived IL-22 in GVHD
      2019 Best Reviewer Award, The Korean Society for Clinical Laboratory Science
      2016 Outstanding Ph.D. Dissertation Award, The Catholic University of Korea, The free radical scavenger NecroX-7 attenuates acute graft-versus-host disease via reciprocal regulation of Th1/regulatory T cells and inhibition of HMGB1 release
      2015 Young Investigator Award, The 6th Meeting of Asian Cellular Therapy Organization, Induction of mixed chimerism for solid-organ transplant tolerance: Comparison between combinatorial cell-based immune modulation using MSCs and Tregs and post-transplant cyclophosphamide
      2015 Excellence Award, The 2nd Korean Society of Experimental Hematology, Biologic effect of high-mobility group Box 1 blockade in acute graft-versus-host disease
      2015 Outstanding Graduate Student Award, 1st Brain Korea 21 Student Fellowship, The Catholic University of Korea
      Technology Transfer as main inventor
      2020 Connext, Composition for preventing or treating graft versus host disease comprising TLR5 agonist derived from flagellin as active ingredient. KR Patent Grant (No. 10-2169663-00-00)
      2020 MitoImmune Therapeutics, Composition for preventing or treating mucositis comprising necrox as effective ingredient. KR Patent Grant (No.KR101718380B1), US Patent Grant (No.US10272092B2), EP Patent Grant (No.EP3216452A2), JP Patent Grant (No.6464277), CN Patent Grant (No.CN107073009A), WO Patent Application (No. WO2016072692)
      2013 LG Life Sciences, A pharmaceutical composition for preventing and treating graft-versus-host disease. KR Patent Application (No. 10-2012-0047510), KR Patent Application (No. 10-2012-0047511), KR Patent Application (No. 10-2013-0031660)

    • Na-youn Kim/ Head of Product Development

      • 25 SCI Research Articles
      • 5 Patent Applications
      • 1 Technology Transfer Case
      • 1 Government-related Project

      Professional Experience

      • 2020  Product Development Division Director, LucasBio
      • 2016-2020  Research Professor, Institute for Translational Research and Molecular Imaging, The Catholic Unversity of Korea
      • 2011-2016  Researcher, Institute for Translational Research and Molecular Imaging, The Catholic Unversity of Korea

      Education

      • 2015-2016  The Catholic University of Korea Biomedical Science Immunology.Microbiology Ph.D
      • 2012-2014  The Catholic University of Korea Biomedical Science Immunology.Microbiology M.S.
      • 2008-2011  Emory University Biology B.S.
      Research Abroad
      2014 Visiting Researcher, Stanford University, Molecular Imaging Program at Stanford
      2013 Visiting Researcher, Stanford University, Molecular Imaging Program at Stanford
      Honors/Awards
      2018 Best Young Abstract Award, European Society for Blood and Marrow Transplantation, Long term outcome of EBV-associated lymphoma treated with post-remission therapy using EBV LMP1 and LMP2a-specific CTLs
      2017 Best Oral Presentation Award, The International Congress of BMT 2017 in conjunction with the Korean society of Blood and Marrow Transplantation, Robust production of cytomegalovirus pp65-specific T cells using a fully automated interferon gamma cytokine capture system
      2016 Outstanding Ph.D. Dissertation Award, The Catholic University of Korea
      2015 Best Abstract and Poster Award, The Korean Association of Immunologists 2015 Fall Conference, IL-21 expressing mesenchymal stem cells prevent lethal B-cell lymphoma through efficient delivery of IL-21 which redirects the immune system to target the tumor
      2015 Best Poster Award, 2015 Seoul St. Mary’s Hospital R&BD Fair - IL-21 expressing mesenchymal stem cells prevent lethal B-cell lymphoma through efficient delivery of IL-21 which redirects the immune system to target the tumor
      2015 Best Abstract Award, The 6th Meeting of Asian Cellular Therapy Organization - Long-term outcome of extranodal NK/T cell lymphoma patients treated with post-remission therapy using EBV LMP1 and LMP2a-specific CTLs
      2015 Outstanding Graduate Student Award, The Catholic University of Korea
      2012 Scholarship for adult stem cell research, The Committee for Life, Archdiocese of Seoul
      2012 Outstanding Oral Presentation Award, The 52nd Spring Meeting, The Korean Society of Hematology

    • Tae-yeon Kim / Head of Business Development

      Professional Experience

      • 2022  Head of Business Development, LucasBio
      • 2006-2002  Director of Biotechnology Laboratory, Boryung Biopharma
      • 1989-2002  Chief Researcher, ,Mogam Institute for Biomedical Research

      Education

      • 1996-2001  KAIST, Molecular Virology, Ph.D.
      • 1998-1990  Pusan National University, Microbiology, M.S.
      • 1982-1988  Pusan National University, Microbiology, B.S
      Research Projects as Principal Investigator
      2020-2022 Development of Tdap Vaccine, Ministry of Health and Welfare
      2017-2020 Localization of cell culture hepatitis A vaccine, Ministry of Health and Welfare
      2015-2020 Development of cell culture technology for Japanese encephalitis vaccine, Ministry of Health and Welfare
      2008-2015 Development of adult Td vaccine, Ministry of Health and Welfare
      Honors/Awards
      2014 Minister of Health and Award for the Promotion of Health and Medical Technology
      National R&D Committee Appointment
      2018 2016-2022 Senior Member of Research Center for Response to Novel Virus Infection, Ministry of Science and Technology
      2014-2016 Technical Member of Korea Technology Commercialization Advisory Group, Ministry of Trade, Industry and Energy
      2010 Advisory Board Member of the Korea Centers for Disease Control and Prevention (KCDC)
    ABOUT
    Company
    Leadership
    Mission & Vision
    Key Personnel
    Advisory Committee Member
    History
    Locations
    TECHNOLOGY
    What is Cell Therapy
    Patents
    Publicaitons
    Clinical Trials
    PIPELINE
    Pipeline Overview
    Immune Cell Therapy
    Stem Cell Therpay
    CONTACT
    News & Events
    Contact Us
    LUCASBIO
    Address. 222, Banpo-daero, Seocho-gu, Seoul, 06591 Korea The Catholic University of Korea Sungeui
    Tel. +82-2-532-2520 ㅣ Fax. +82-2-534-2520
    COPYRIGHT(c) 2020 LUCASBIO. ALL RIGHTS RESERVED.    Email : lucasbio@lucasbio.com
    Address. 222, Banpo-daero, Seocho-gu, Seoul, 06591 Korea The Catholic University of Korea Sungeui
    Tel. +82-2-532-2520 ㅣ Fax. +82-2-534-2520
    COPYRIGHT(c) 2020 LUCASBIO. ALL RIGHTS RESERVED.
    Email : lucasbio@lucasbio.com